Under pathological conditions such as cancer, programmed death receptor-ligand 1 (PD-L1) expression is often upregulated in tumour cells, and PD-L1 binds to programmed cell death protein 1 (PD-1) on T cells, resulting in potent immune suppression and tumour immune escape4–9. This evidence concerns the gene CD274 and cancer.